Samsung Medical Center
Leukemia treatment cost in South Korea typically depends on the complex diagnostic phase and chosen therapy, with a bone marrow biopsy running from AUD $1,012 to AUD $2,168. Primary interventions such as leukemia chemotherapy range from AUD $31,795 to AUD $79,489, while advanced CAR T-cell therapy costs between AUD $556,421 and AUD $744,304. Patients save approximately 50–70% compared to Australia and the United States, with top-tier care concentrated in Seoul.
Typical Leukemia Treatment Costs in South Korea
Bookimed Expert Insight: For complex cases requiring massive surgical volume, Asan Medical Center treats over 180,000 patients annually. Its oncology team handles nearly half of South Korea’s heart transplants, showing high skill in critical care. Patients seeking digital safety protocols should consider Seoul National University Bundang Hospital. It uses the BESTcare system to prevent medical errors during high-intensity treatments like chemotherapy.
| Republic of Korea | Thailand | Turkey | |
| Chemotherapy for breast cancer | from AUD $27,749 | from AUD $4,336 | from AUD $1,734 |
| CAR T-cell therapy | from AUD $556,421 | from AUD $361,312 | from AUD $216,787 |
| Leukemia chemotherapy | from AUD $31,795 | from AUD $21,679 | from AUD $11,562 |
| Therapeutic Apheresis | - | - | from AUD $1,951 |
No hidden fees – just official clinic prices. Pay at the clinic for Leukemia treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Leukemia treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Leukemia treatment journey.
Bone marrow transplant services in South Korea are highly specialised and recognised worldwide. Major Seoul facilities, such as Samsung Medical Center and Asan Medical Center, routinely handle complex leukaemia cases. These institutions use CAR T-cell therapy and digital systems to maintain success rates near 90%.
Bookimed Expert Insight: Many countries have high-volume centres. However, South Korea stands out for tech-driven safety. Asan Medical Center performs 65,000+ operations annually. The BESTcare digital system across major Seoul clinics further reduces medical errors during leukaemia recovery.
Patient Consensus: Patients value the efficient digital record systems and JCI-accredited facilities in Seoul. The availability of intensive chemotherapy and CAR T-cell options provides confidence for complex leukaemia diagnoses.
Hospitals in the Republic of Korea offer leukaemia treatments including CAR-T therapy, such as Kymriah and Yescarta. Specialist centres report 70-90% efficacy for specific blood cancers. Leading Seoul hospitals provide these cell-based immunotherapies alongside bone marrow transplants and digital diagnostic protocols.
Bookimed Expert Insight: Many countries offer CAR-T therapy. However, Seoul hospitals like Severance and Samsung Medical Center treat massive volumes. Severance alone sees 4,000,000 patients annually. This scale allows departments to specialise in rare leukaemia subtypes. Smaller regional hospitals elsewhere may rarely see these cases.
Patient Consensus: Patients value the high-quality infrastructure in the Republic of Korea. They emphasise the need to confirm if CAR-T is available for specific subtypes before travelling.
Top South Korean hospitals for leukaemia care include Samsung Medical Center, Asan Medical Center, and Severance Hospital. These centres hold JCI and KOIHA accreditations. They offer therapies like CAR T-cell and stem cell transplants. Seoul National University Hospital also provides leading onco-haematology services.
Bookimed Expert Insight: Samsung Medical Center and Severance Hospital have the scale to treat millions of patients. This volume is a critical safety signal. It means haematology teams handle rare leukaemia subtypes and transplant complications daily.
Patient Consensus: Patients recommend large academic centres in Seoul for their specialist haematology-oncology teams. These units also provide vital intensive-care support. When travelling from Australia, choose hospitals with dedicated international coordinators. They help manage complex bone marrow transplant pathways and English-language communication.
Major South Korean hospitals provide English-language support for international leukaemia patients. Facilities like Severance Hospital and Ewha Womans University Medical Center employ English-speaking coordinators. Medical interpreters assist with complex protocols like CAR T-cell therapy and chemotherapy.
Bookimed Expert Insight: South Korea ranks fifth globally for medical requests on our platform. Leukaemia patients find the best support at digitalised centres. Seoul National University Bundang Hospital was the first fully digital hospital there. This technology reduces medical errors during complex haematology treatments. It also makes sharing records with Australian GPs much easier.
Patient Consensus: Patients find that international centres in Seoul provide smooth communication. They appreciate how coordinators handle logistics and explain medical steps clearly during treatment.